SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will present at the 14th annual BIO CEO & Investor Conference at 8:30 a.m. EST / 5:30 a.m. PST on Tuesday, February 14, 2012, in New York. During the presentation, Dr. Morrissey will discuss the company’s development program and plans for cabozantinib, and review the most recent publicly available data for the compound. He will also provide a general business update, including the company’s financial outlook for 2012.
